Fas-p53 pathway drives metabolic dysfunction and obesity-linked insulin resistance

Researchers unveil Fas-p53 axis as a key regulator in adipocyte metabolism, linking it to obesity and insulin sensitivity through energy expenditure and inflammation pathways.

Pharmalittle: We’re reading about Sanders and Novo Nordisk CEO sparring, Roche refocusing, and more

Hello, everyone, and how are you today? We are doing just fine, thank you, and given that the middle of the week is here, we

September 25, 2024

Lonza Delivers Solid 2023 Performance with 10.9% CER Sales Growth and 29.8% CORE EBITDA Margin – Biotech Investments

Lonza Group AG / Key word(s): Annual Results 26-Jan-2024 / 06:50 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

January 27, 2024

6 Ways AI is Reshaping Healthcare Diagnostics & Treatment

Raman Parthasarathy, Business Unit Head, Fusemachines Of the many industries witnessing AI-led transformation, healthcare happens to be one. Today, AI’s promise in healthcare extends beyond

June 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.